It has been suggested that combination therapy is more effective in preclinical model studies because radiation can increase the expression level of the NKG2D protein in tumor cells, making the cancer cells more vulnerable to NK cell attack (Demaria et al., 2013). This evidence concerns the gene KLRK1 and neoplasm.